DR. KAMBIZ THOMAS MOAZED, MD
Medical Practice at Broadway, New York, NY
License number
New York 149314
Category
Medical Practice
Type
Ophthalmology
Address
Address
4337 Broadway, New York, NY 10033
Phone
(212) 568-6300
(516) 542-5556 (Fax)
(646) 680-2888
(516) 542-5556 (Fax)
(646) 680-2888
Personal information
See more information about KAMBIZ THOMAS MOAZED at radaris.comName
Address
Phone
East Islip, NY
100 Fire Island Ave, Babylon, NY 11702
100 Fire Island Blvd, Fire Island Pines, NY 11782
106 85Th St, New York, NY 10028
172 Amsterdam Ave, New York, NY 10023
Professional information
Dr. Kambiz T Moazed, New York NY - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
21 E 22Nd St, New York 10010
(212) 460-7800 (Phone), (212) 460-7877 (Fax)
2465 Broadway, New York 10025
(212) 712-1000 (Phone), (917) 441-3189 (Fax)
4337 Broadway, New York 10033
(212) 568-6300 (Phone), (212) 544-5079 (Fax)
(212) 460-7800 (Phone), (212) 460-7877 (Fax)
2465 Broadway, New York 10025
(212) 712-1000 (Phone), (917) 441-3189 (Fax)
4337 Broadway, New York 10033
(212) 568-6300 (Phone), (212) 544-5079 (Fax)
Certifications:
Ophthalmology, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Ahwaz University School of Medicine / Shahid Chamran University
Stanford U Med Ctr
Fell Harvard U Mass Ee Infi
Harvard U Mass Ee Infirm
Edward Harkness Eye Inst
Ahwaz University School of Medicine / Shahid Chamran University
Stanford U Med Ctr
Fell Harvard U Mass Ee Infi
Harvard U Mass Ee Infirm
Edward Harkness Eye Inst
Md At Manhattan's Physicians Group
Position:
MD at Manhattan's Physicians Group
Location:
Greater New York City Area
Industry:
Medical Practice
Work:
Manhattan's Physicians Group
-
MD
Kambiz Thomas Moazed, New York NY
Specialties:
Ophthalmology, Surgery
Work:
Manhattan's Physician Group
21 E 22Nd St, New York, NY 10010 Manhattan's Physician Group
4337 Broadway, New York, NY 10033 Ophth Dpt.
506 Malcolm X Blvd, New York, NY 10037
21 E 22Nd St, New York, NY 10010 Manhattan's Physician Group
4337 Broadway, New York, NY 10033 Ophth Dpt.
506 Malcolm X Blvd, New York, NY 10037
Education:
Jundi-Shapour University (Iran *, Massachusetts Eye And Ear Infirmary *Ophthalmology, Stanford Hospital and Clinics *Ophthalmology, Massachusetts Eye And Ear Infirmary *Ophthalmology, New York Presbyterian Hospital / Columbia *Ophthalmology
Kambiz Thomas Moazed, New York NY
Specialties:
Ophthalmologist
Address:
2465 Broadway, New York, NY 10025
21 E 22Nd St, New York, NY 10010
1111 Amsterdam Ave, New York, NY 10025
21 E 22Nd St, New York, NY 10010
1111 Amsterdam Ave, New York, NY 10025
Education:
Ahvaz Jondishapour University of Medical Sciences - Doctor of Medicine
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
Transnasal Lacrimal Insert
US Patent:
5993407, Nov 30, 1999
Filed:
Oct 25, 1996
Appl. No.:
8/736902
Inventors:
Kambiz Thomas Moazed - New York NY
International Classification:
A61M 500
US Classification:
604 8
Abstract:
A temporary transnasal lacrimal insert is used in a surgical procedure for improving drainage from a patient's lacrimal sac to his or her nasal cavity. The insert includes a tubular member with a proximal end and an enlarged distal end. The insert also includes an attachment element about which ends of a tube can be fastened. In the procedure, a hole is created extending from the lacrimal sac into the nasal cavity using surgical techniques or a laser probe. Then, opposite ends of a tube are introduced through the patient's upper and lower puncta, through the patient's upper and lower canaliculi, through the lacrimal sac, through the hole, and into the nasal cavity. The ends of the tube are then threaded through the passage in the insert. The insert is then placed from the nasal cavity into the hole by forcing the proximal end of the insert through the hole and into the lacrimal sac, and abutting the enlarged distal end, which is larger than the hole, against a surface in the nasal cavity surrounding the hole. The ends of the tube are then fastened to the attachment element of the insert.
Transnasal Lacrimal Insert
US Patent:
2002003, Mar 14, 2002
Filed:
May 22, 2001
Appl. No.:
09/862744
Inventors:
Kambiz Moazed - New York NY, US
International Classification:
A61M005/00
US Classification:
604/008000
Abstract:
A temporary transnasal lacrimal insert is used in a surgical procedure for improving drainage from a patient's lacrimal sac to his or her nasal cavity. The insert includes a tubular member with a proximal end and an enlarged distal end. The insert also includes an attachment element about which ends of a silastic tube can be fastened. In the procedure, a hole is created extending from the lacrimal sac into the nasal cavity using surgical techniques or a laser probe. Then, opposite ends of a silastic tube are introduced through the patient's upper and lower puncta, through the patient's upper and lower canaliculi, through the lacrimal sac, through the hole, and into the nasal cavity. The ends of the silastic tube are then threaded through the passage in the insert. The insert is then placed from the nasal cavity into the hole by forcing the proximal end of the insert through the hole and into the lacrimal sac, and abutting the enlarged distal end, which is larger than the hole, against a surface in the nasal cavity surrounding the hole. The ends of the silastic tube are then fastened to the attachment element of the insert. Excess tube extending into the nasal cavity is then cut short to reduce nasal irritation. After the hole has sufficiently healed in about 3-6 months, the silastic tube and the insert are removed.
Transnasal Lacrimal Insert
US Patent:
2003013, Jul 10, 2003
Filed:
Feb 25, 2003
Appl. No.:
10/373508
Inventors:
Kambiz Moazed - New York NY, US
International Classification:
A61M005/00
US Classification:
604/008000
Abstract:
A temporary transnasal lacrimal insert is used in a surgical procedure for improving drainage from a patient's lacrimal sac to his or her nasal cavity. The insert includes a tubular member with a proximal end and an enlarged distal end. The insert also includes an attachment element about which ends of a silastic tube can be fastened. In the procedure, a hole is created extending from the lacrimal sac into the nasal cavity using surgical techniques or a laser probe. Then, opposite ends of a silastic tube are introduced through the patient's upper and lower puncta, through the patient's upper and lower canaliculi, through the lacrimal sac, through the hole, and into the nasal cavity. The ends of the silastic tube are then threaded through the passage in the insert. The insert is then placed from the nasal cavity into the hole by forcing the proximal end of the insert through the hole and into the lacrimal sac, and abutting the enlarged distal end, which is larger than the hole, against a surface in the nasal cavity surrounding the hole. The ends of the silastic tube are then fastened to the attachment element of the insert. Excess tube extending into the nasal cavity is then cut short to reduce nasal irritation. After the hole has sufficiently healed in about 3-6 months, the silastic tube and the insert are removed.
Method And System For Effecting Changes In Pigmented Tissue
US Patent:
2011028, Nov 17, 2011
Filed:
Jan 29, 2010
Appl. No.:
13/138260
Inventors:
Kambiz Thomas Moazed - New York NY, US
International Classification:
A61K 31/05, A61K 31/13, A61K 31/138, A61K 31/541, A61K 31/136, A61K 31/4178, A61K 31/47, A61K 31/485, A61K 31/7105, A61K 39/08, A61K 31/191, A61K 36/62, A61K 31/655, A61P 27/06, A61P 35/00, A61K 31/352
US Classification:
4242391, 514731, 514456, 514733, 514662, 514651, 5142278, 514648, 514397, 514734, 514307, 514282, 514 44 A, 514455, 514557, 424778, 514150
Abstract:
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are nanoparticle compositions for lightening the pigmented tissues or treating a pigmented tissue related disease.
Method And System For Effecting Changes In Pigmented Tissue
US Patent:
2012007, Mar 29, 2012
Filed:
Jul 21, 2010
Appl. No.:
13/261047
Inventors:
Kambiz Thomas Moazed - New York NY, US
International Classification:
A61K 9/00, A61K 31/352, A61K 31/222, A61K 31/541, A61K 31/196, A61K 31/4178, A61K 31/472, A61K 31/485, A61K 31/13, A61K 31/713, A61K 38/16, A61K 36/185, A61K 31/23, A61K 31/557, A61K 31/655, A61K 31/136, C07F 3/06, A61P 27/02, A61P 43/00, A61P 27/06, A61P 35/00, A61K 31/05, B82Y 5/00
US Classification:
424427, 514731, 514733, 514456, 514546, 5142278, 514567, 514397, 514734, 514307, 514282, 514662, 514 44 A, 514 208, 514455, 424778, 514547, 514573, 514150, 514454, 514641, 556130, 977773, 977906
Abstract:
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are nanoparticle compositions for lightening the pigmented tissues or treating a pigmented tissue related disease.
Method And System For Effecting Changes In Pigmented Tissue
US Patent:
2012020, Aug 16, 2012
Filed:
Nov 30, 2011
Appl. No.:
13/373797
Inventors:
Kambiz Thomas Moazed - New York NY, US
International Classification:
A61K 9/00, A61K 39/08, A61K 33/26, A61K 33/24, A61K 31/7088, A61K 31/13, A61K 31/05, A61P 27/06, A61P 35/00, A61P 27/02, A61K 8/40, A61K 31/352, B82Y 5/00
US Classification:
424427, 424 62, 4242391, 424641, 424646, 424649, 514 44 A, 514454, 514662, 514731, 977773, 977906
Abstract:
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are compositions for lightening or darkening the pigmented tissues or treating a pigmented tissue disease.